NUAK1 and cervical cancer: Recently, Escalona et al. demonstrated that ARK5 enhanced mitochondrial ATP production in several cancer cells, including breast, colon, and cervical cancers [13], indicating that ARK5 is involved in mitochondrial activity in cancer.